Trademark Overview
On Wednesday, July 3, 2024, a trademark application was filed for MCDERMOTT+ with the United States Patent and Trademark Office. The USPTO has given the MCDERMOTT+ trademark a serial number of 98632487. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, July 3, 2024. This trademark is owned by McDermott Will & Emery LLP. The MCDERMOTT+ trademark is filed in the Advertising, Business and Retail Services, Insurance & Financial Services, Computer & Software Services & Scientific Services, Personal, and Legal & Social Services categories with the following description:
Insurance information in the field of private and public payer coverage
Healthcare consulting services, namely, business management consulting in the field of healthcare, and business and management consulting for healthcare providers and related businesses; commercial lobbying services in the healthcare field; providing public policy consultancy, public advocacy services on behalf of businesses facing policy or regulatory changes that present barriers to market entry, business efficiency or slow rates of return on investments, and commercial lobbying services; data modeling services in the field of healthcare for business purposes, namely, financial analysis, budget impact and cost effectiveness for congressional budget office and office of management and budget impact models; business consulting in the field of public and private payer coverage; consulting in the field of healthcare coding, business pricing and management services
Political lobbying services; personal advocacy services, namely, advocating for health policy alternatives necessitated by policy or regulatory changes that raise barriers to market entry, challenge business efficiency or viability, threaten to reduce rates of return for investments, or slow customer adoption of health items or services
Computer data modeling services involving data relating to healthcare financial analysis, budget impact and cost-effectiveness models, assessment of cost impact of proposed legislation on medicare expenditures, analysis of national and local coverage determinations, and modeling of alternative outcomes, analysis modeling in support of litigation, due diligence or transaction specific client needs